Overview

Cross Linking for Treatment of Corneal Infection

Status:
Terminated
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
This study is comparing 45 minute and 30 minute treatment durations with the UVX corneal cross linking system to treat corneal infections.
Phase:
N/A
Details
Lead Sponsor:
Price Vision Group
Collaborator:
Cornea Research Foundation of America
Treatments:
Riboflavin